Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Hikma Pharmaceuticals
Current Parent Company: Hikma Pharmaceuticals
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $150,000,000
Year: 2024
Date: February 1, 2024
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: opioid crisis litigation
Mega-Scandal: Opioid Crisis
Violation Description: Hikma Pharmaceuticals will pay $150 million to resolve allegations of its role in fueling the opioid crisis. Hikma allegedly failed to monitor and report suspicious opioid orders from potentially illegal distributors, even as personnel knew their systems were inadequate and prone to failure.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.